The researchers successfully performed the transplantation of 11 patient-derived GBM IDH wild-type cell cultures, which were genetically modified to express green fluorescent protein (GFP), into zebrafish embryos that were only one day old. The gene discussed is IDH1; the disease is glioblastoma.